Korro Bio FY2025 EPS Forecast Reduced by Chardan Capital
Korro Bio, Inc. (NASDAQ:KRRO – Free Report) – Stock analysts at Chardan Capital cut their FY2025 EPS estimates for Korro Bio in a report released on Wednesday, May 14th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($10.00) for the year, down from their previous estimate of […]
